FierceBiotech

One of the world’s leading investment firms has broken its [...]

Autoimmune specialist Aurinia, which named Kevin Tang as its new [...]

AstraZeneca isn’t letting a death in a China trial detract [...]

Otsuka Pharmaceutical has acquired Transcend Therapeutics for $700 million upfront [...]

Takeda has posted phase 3 data on an autoimmune asset [...]

AstraZeneca’s chronic obstructive pulmonary disease drug candidate has hit the [...]

Novartis has penned a $2 billion deal for a biotech [...]

Seasoned biotech takeover titan Kevin Tang has struck again. After [...]

Pulmatrix may have been discarded by Cullgen, but the inhaled [...]

Oral peptide specialist Pinnacle Medicines has secured an $89 million [...]